Skip to main content
. Author manuscript; available in PMC: 2013 Mar 12.
Published in final edited form as: J Nucl Med. 2012 Feb 13;53(3):363–370. doi: 10.2967/jnumed.111.098319

FIGURE 3.

FIGURE 3

Time−activity distribution in liver, tumor, normal breast, and blood (from ventricular chamber). Data were normalized for 370-MBq injection (patient 5, dynamic cohort) with ER+ and PR+ tumor. Uptake of 18F-FFNP in this patient’s tumor was twice that in her normal breast.